We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck to Supply U.S. With Up to 100,000 Doses of Investigational COVID-19 Treatment
Merck to Supply U.S. With Up to 100,000 Doses of Investigational COVID-19 Treatment
Merck has signed a contract to supply up to 100,000 doses of its experimental COVID-19 treatment, MK-7110, to the U.S. government for $356 million, provided the investigational biologic earns the FDA’s approval or Emergency Use Authorization.